Key result
Exosomes and their specific microRNA cargos show potential as diagnostic markers, prognostic indicators, and therapeutic agents across various cardiovascular diseases.
Exosomes show promise as diagnostic, prognostic, and therapeutic tools in cardiovascular diseases, highlighting the need for standardized isolation and evaluation methods.
Exosome applications in CVD remain investigational; supports hypothesis generation but requires standardization before clinical adoption.
Exosomes, as one of the extracellular vesicles' subgroups, played an important role in the cell to cell communication. The cargos and surface protein of exosomes have been known to affect the cardiovascular system both positively and negatively in chronic heart failure, ischemic heart disease, and atherosclerosis. There have been several exosomes that emerged as potential diagnostic and prognostic markers in cardiovascular patients. However, the conditions affecting the patients and the method of isolation should be considered to create a standardized normal value of the exosomes and the components. CPC-derived exosomes, ADSCs-derived exosomes, and telocyte- derived exosomes have been proven to be capable of acting as a therapeutic agent in myocardial infarction models. Exosomes have the potential to become a diagnostic marker, prognostic marker, and therapeutic agent in cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Laksono et al. (2021) conducted a review in Cardiovascular diseases. Exosomes was evaluated. Exosomes and their specific microRNA cargos show potential as diagnostic markers, prognostic indicators, and therapeutic agents across various cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: